Author: admin

Filter by Topic
MedTech Innovator Crowns Mirai Medical Among Top Innovators for 2023
Read More
Mirai Medical attends the Australasian Melanoma Conference (AMC) 2023
Read More
Mirai Medical treats the first skin cancer patient in Australia with ePORE® therapy
Read More
The first clinical paper published using electroporation in conjunction with calcium for the treatment of colorectal cancer
Read More
First live surgery demonstration of Mirai Medical’s ePORE® therapy for the treatment of gastrointestinal cancers
Read More
Mirai Medical appoints Paraic Curtis to the board
Read More
First patient with oesophageal cancer is treated in Germany using ePORE® therapy with EndoVE®
Read More
Mirai Medical’s ePORE® therapy with EndoVE® is launched in Spain
Read More
Mirai Medical launch EndoVE® probe in Leeds
Read More
Galway-based Mirai Medical raises €3m in funding
Read More

Contact Us

By clicking send, you confirm you have read and agreed to Mirai Medical's Privacy Policy.
Twitter Linkedin-in Youtube
ePORE Therapy White Logo
Address:
Mirai Medical
Unit 5, Howley Court
Oranmore
Galway
Ireland
Email:
info@mirai-medical.com
Mirai Medical logo white

© Copyright 2023 MIRAI MEDICAL. All Rights Reserved.

Privacy & Cookies
ePORE® therapy, EndoVE® and CUTIS are approved for commercialisation in the European Union, United Kingdom and Australia. ePORE® therapy, EndoVE® and CUTIS are not cleared by FDA for commercialisation in the USA.

WEEE Ireland Certificate of Registration MIR 100

Website by Proactive Design & Marketing